Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand and treat Beard Alopecia Areata due to limited current knowledge and evidence.

The document concludes that "Dictamnus" has a rich cultural history and potential as a herbal medicine, warranting more research into its effects and safety.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.

Nitrogen mustard was not very effective for hair regrowth in alopecia areata and has potential skin cancer risk.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

New treatments for lupus show promise, but more research is needed, especially for children.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

The cause of alopecia areata was unknown, and while various treatments existed, no best treatment was agreed upon.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Androgen deprivation therapy might be better for preventing COVID-19 than treating it.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Platelet-Rich Plasma and stem cell therapy can increase hair count and density, but the best method for preparation and treatment still needs to be determined.

Platelet-rich plasma and microneedling could potentially help hair growth in people with alopecia areata, but more research is needed.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.